Skip to Content

UPMC Department of Neurology Hosted the Multiple Sclerosis Symposium: Clinical Advances of Multiple Sclerosis Diagnosis and Treatment

October 23, 2024

On October 4, 2024, the UPMC Department of Neurology hosted the Multiple Sclerosis Symposium: Clinical Advances of Multiple Sclerosis Diagnosis and Treatment, a one-day symposium highlighting innovations and advances in multiple sclerosis (MS) care.

Under the direction of nationally renowned leader in MS care and treatment, Ingrid Loma-Miller, MD, alongside co-director Emily Guerriero, PA, the symposium was centered around current state-of-the-art treatment methods and the future of MS care.

This symposium featured focused and practical topics designed for advanced professionals involved in treating patients with MS and other neuro-immunological disorders including neurologists, physical medicine and rehabilitation physicians, physical therapists, advanced practice providers, nurses, and students.

View the event videos below.

Diagnosing Multiple Sclerosis, Rock A. Heyman, MD

FX Perspectives: Can The Unexpected Strength In DXY Continue?
In our April FX podcast, Our Head of FX Strategy presented a case for the broad-based DXY index to eventually fall to the lower end of its 102-104 range in the second quarter. However, things have played out different since, with the index now in a higher 104-107 range. What are the factors at play and will this continue?
More
Play
Share
Video info
00:00
Play
Seek 10 seconds backwards
Seek 10 seconds forward
00:00 / 00:00
Mute
Enable Captions
Settings
Picture in picture
Fullscreen

Multiple Sclerosis and Pregnancy | Ingrid Loma-Miller, MD

FX Perspectives: Can The Unexpected Strength In DXY Continue?
In our April FX podcast, Our Head of FX Strategy presented a case for the broad-based DXY index to eventually fall to the lower end of its 102-104 range in the second quarter. However, things have played out different since, with the index now in a higher 104-107 range. What are the factors at play and will this continue?
More
Play
Share
Video info
00:00
Play
Seek 10 seconds backwards
Seek 10 seconds forward
00:00 / 00:00
Mute
Enable Captions
Settings
Picture in picture
Fullscreen

Disease Modifying Therapies , Rock A. Heyman, MD, and Emily Guerriero, PA-C

FX Perspectives: Can The Unexpected Strength In DXY Continue?
In our April FX podcast, Our Head of FX Strategy presented a case for the broad-based DXY index to eventually fall to the lower end of its 102-104 range in the second quarter. However, things have played out different since, with the index now in a higher 104-107 range. What are the factors at play and will this continue?
More
Play
Share
Video info
00:00
Play
Seek 10 seconds backwards
Seek 10 seconds forward
00:00 / 00:00
Mute
Enable Captions
Settings
Picture in picture
Fullscreen

Autoimmune Encephalitis, Cigdem Isitan-Alkawadri, MD

FX Perspectives: Can The Unexpected Strength In DXY Continue?
In our April FX podcast, Our Head of FX Strategy presented a case for the broad-based DXY index to eventually fall to the lower end of its 102-104 range in the second quarter. However, things have played out different since, with the index now in a higher 104-107 range. What are the factors at play and will this continue?
More
Play
00:00
Play
Seek 10 seconds backwards
Seek 10 seconds forward
00:00 / 00:00
Mute
Settings
Picture in picture
Fullscreen

Imaging in Multiple Sclerosis, Marion Hughes, JD, MD

FX Perspectives: Can The Unexpected Strength In DXY Continue?
In our April FX podcast, Our Head of FX Strategy presented a case for the broad-based DXY index to eventually fall to the lower end of its 102-104 range in the second quarter. However, things have played out different since, with the index now in a higher 104-107 range. What are the factors at play and will this continue?
More
Play
00:00
Play
Seek 10 seconds backwards
Seek 10 seconds forward
00:00 / 00:00
Mute
Settings
Picture in picture
Fullscreen

Paraneoplastic (CNS) Neurologic Syndromes, Jenny Linnoila, MD, PhD

FX Perspectives: Can The Unexpected Strength In DXY Continue?
In our April FX podcast, Our Head of FX Strategy presented a case for the broad-based DXY index to eventually fall to the lower end of its 102-104 range in the second quarter. However, things have played out different since, with the index now in a higher 104-107 range. What are the factors at play and will this continue?
More
Play
00:00
Play
Seek 10 seconds backwards
Seek 10 seconds forward
00:00 / 00:00
Mute
Settings
Picture in picture
Fullscreen

Multiple Sclerosis Symposium, Case Presentations

FX Perspectives: Can The Unexpected Strength In DXY Continue?
In our April FX podcast, Our Head of FX Strategy presented a case for the broad-based DXY index to eventually fall to the lower end of its 102-104 range in the second quarter. However, things have played out different since, with the index now in a higher 104-107 range. What are the factors at play and will this continue?
More
Play
00:00
Play
Seek 10 seconds backwards
Seek 10 seconds forward
00:00 / 00:00
Mute
Settings
Picture in picture
Fullscreen